These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24289998)

  • 41. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Steroid and protein hormone concentrations in serum and follicular fluid after stimulation for in vitro fertilization].
    Zech H; Weiss P; Fritzsche H; Zech J; Daxenbichler G
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):483-6. PubMed ID: 1397945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.
    Boostanfar R; Shapiro B; Levy M; Rosenwaks Z; Witjes H; Stegmann BJ; Elbers J; Gordon K; Mannaerts B;
    Fertil Steril; 2015 Jul; 104(1):94-103.e1. PubMed ID: 26003273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer.
    Papanikolaou EG; Kolibianakis EM; Pozzobon C; Tank P; Tournaye H; Bourgain C; Van Steirteghem A; Devroey P
    Fertil Steril; 2009 Mar; 91(3):949-52. PubMed ID: 17555751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled ovarian stimulation using a long gonadotropin-releasing hormone antagonist protocol: a proof of concept and feasibility study.
    Weissman A; Ravhon A; Steinfeld Z; Nahum H; Golan A; Levran D
    Gynecol Obstet Invest; 2013; 76(2):113-8. PubMed ID: 23920048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Highly purified FSH for stimulation of down regulated cycles in the in vitro fertilization program].
    Sydow P; Lisse K; Schürenkämper P; Scheiber I; Bloechle M
    Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):146-50. PubMed ID: 8674961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients.
    Escudero E; Bosch E; Crespo J; Simón C; Remohí J; Pellicer A
    Fertil Steril; 2004 Mar; 81(3):562-6. PubMed ID: 15037403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy.
    Huirne JA; van Loenen AC; Schats R; McDonnell J; Hompes PG; Schoemaker J; Homburg R; Lambalk CB
    Hum Reprod; 2005 Feb; 20(2):359-67. PubMed ID: 15567880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basal and cycle androgen levels correlate with in vitro fertilization stimulation parameters but do not predict pregnancy outcome.
    Frattarelli JL; Gerber MD
    Fertil Steril; 2006 Jul; 86(1):51-7. PubMed ID: 16716312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is measurement of progesterone level prior to FSH stimulation useful in GnRH-antagonist cycles?
    Listijono D; Kilani S; Tilia L; Garrett D; Chapman M
    Hum Fertil (Camb); 2015; 18(4):234-7. PubMed ID: 25997693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of ovarian reserve by using the follicle-stimulating hormone isoform distribution pattern to predict the outcome of in vitro fertilization.
    Letterie GS; Lee JS; Padmanabhan V
    Fertil Steril; 2006 Nov; 86(5):1547-9. PubMed ID: 16999956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome: a prospective randomized study.
    Stadtmauer LA; Sarhan A; Duran EH; Beydoun H; Bocca S; Pultz B; Oehninger S
    Fertil Steril; 2011 Jan; 95(1):216-20. PubMed ID: 20594551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of premature luteinizing hormone increases among high ovarian responders undergoing a gonadotropin-releasing hormone antagonist ovarian stimulation protocol.
    Geng Y; Lai Q; Xun Y; Jin L
    Int J Gynaecol Obstet; 2018 Jul; 142(1):97-103. PubMed ID: 29542120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follicular progesterone elevations with ovulation induction for IVF.
    Kasum M; Simunić V; Vrčić H; Stanić P; Orešković S; Beketić-Orešković L
    Gynecol Endocrinol; 2014 Aug; 30(8):537-41. PubMed ID: 24841851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical application of gonadotrophin for IVF-ET].
    Kajihara T; Ishihara O
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():237-41. PubMed ID: 16689315
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone agonist and antagonists, on follicular fluid stem cell factor and serum urocortin 1 levels on the day of oocyte retrieval.
    Celik O; Celik E; Yilmaz E; Celik N; Turkcuoglu I; Ulas M; Kumbak B; Aktan E; Ozerol I
    Arch Gynecol Obstet; 2013 Dec; 288(6):1417-22. PubMed ID: 23801011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.